David R. Elmaleh

Scientific Founder & Chairman, Board of Directors at AZTherapies

David founded AZTherapies in 2011, he previously founded Molecular Insight (formerly Biostream), Mersana (formerly NanoPharma), and Puretech Health. He also currently serves as Associate Professor, Harvard Medical School, and Director of Contrast Media Chemistry at Massachusetts General Hospital.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


AZTherapies

AZTherapies is a Boston-based life science company targeting neuroinflammation and developing novel therapies to treat neurodegenerative diseases.


Industries

Employees

11-50

Links